Skip to content

Month: April 2022

Should low-risk prostate cancer be left to active monitoring?

By Veronika Kuvshinova

According to Specialist in Medical Oncology and Radiotherapy Timo Joensuu at Docrates Cancer Center, active treatment of prostate cancer is particularly supported by the fact that the treatment can nowadays be performed using radiotherapy with minimal side effects. The latest radiotherapy techniques have not been found to involve even the risk of secondary cancer.There is … Continued

Docrates uses the newest drug therapies for breast cancer

By Anna-Sofia Malmi

Before a new drug is introduced at Docrates Cancer Center, there must be sufficient research-based medical evidence to support its effectiveness and safety. In addition, the doctor always assesses the expected benefits and possible risks of using the drug for each patient and considers the use of the drug on that basis. The drug is … Continued